Artivion, Inc. (AORT) stock
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/305% below fair value
$18.54+0.27 (+1.48%)
Close on Nov 18, 2026Market cap $903.94MP/E –Yield –
Artivion net income
Net income is the profit left for shareholders after every expense, interest and tax.
Artivion's net income for the twelve months ending Jun 30, 2026 was -$3.17M. For fiscal 2025 it was $9.77M. Over ten years it grew 9.3% a year on average. The highest annual figure on record is $16.17M in fiscal 2013.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.77M | – |
| FY2024 | Dec 31, 2024 | -$13.36M | – |
| FY2023 | Dec 31, 2023 | -$30.69M | – |
| FY2022 | Dec 31, 2022 | -$19.19M | – |
| FY2021 | Dec 31, 2021 | -$14.83M | – |
| FY2020 | Dec 31, 2020 | -$16.68M | -1069.9% |
| FY2019 | Dec 31, 2019 | $1.72M | – |
| FY2018 | Dec 31, 2018 | -$2.84M | -176.7% |
| FY2017 | Dec 31, 2017 | $3.70M | -65.6% |
| FY2016 | Dec 31, 2016 | $10.78M | +169.1% |
| FY2015 | Dec 31, 2015 | $4.01M | -45.3% |
| FY2014 | Dec 31, 2014 | $7.32M | -54.7% |
| FY2013 | Dec 31, 2013 | $16.17M | +103.5% |
| FY2012 | Dec 31, 2012 | $7.95M | +7.8% |
| FY2011 | Dec 31, 2011 | $7.37M | +86.9% |
| FY2010 | Dec 31, 2010 | $3.94M | -54.6% |
| FY2009 | Dec 31, 2009 | $8.68M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$13.51M | -1104.5% |
| Q1 FY2026 | Mar 31, 2026 | $1.42M | – |
| Q4 FY2025 | Dec 31, 2025 | $2.43M | – |
| Q3 FY2025 | Sep 30, 2025 | $6.50M | – |
| Q2 FY2025 | Jun 30, 2025 | $1.35M | – |
| Q1 FY2025 | Mar 31, 2025 | -$505.00K | -106.7% |
| Q4 FY2024 | Dec 31, 2024 | -$16.48M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.29M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.12M | – |
| Q1 FY2024 | Mar 31, 2024 | $7.53M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.98M | -283.3% |
| Q3 FY2023 | Sep 30, 2023 | -$9.80M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.38M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.53M | – |
| Q4 FY2022 | Dec 31, 2022 | $2.17M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.71M | -229.6% |
| Q2 FY2022 | Jun 30, 2022 | -$4.26M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.39M | – |
| Q4 FY2021 | Dec 31, 2021 | -$20.10M | – |
| Q3 FY2021 | Sep 30, 2021 | $10.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.18M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.14M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.46M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.87M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.69M | -230.3% |
| Q1 FY2020 | Mar 31, 2020 | -$6.67M | – |
| Q4 FY2019 | Dec 31, 2019 | -$681.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$134.00K | -108.6% |
| Q2 FY2019 | Jun 30, 2019 | $2.83M | +1153.1% |
| Q1 FY2019 | Mar 31, 2019 | -$297.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$776.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $1.57M | +18.1% |
| Q2 FY2018 | Jun 30, 2018 | $226.00K | -92.9% |
| Q1 FY2018 | Mar 31, 2018 | -$3.86M | -273.4% |
| Q4 FY2017 | Dec 31, 2017 | -$3.01M | -203.8% |
| Q3 FY2017 | Sep 30, 2017 | $1.33M | -55.7% |
| Q2 FY2017 | Jun 30, 2017 | $3.16M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.22M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.90M | – |
| Q3 FY2016 | Sep 30, 2016 | $2.99M | – |
See a number that looks wrong?